Typhoid vaccine Vi polysaccharide - Bharat Biotech

Drug Profile

Typhoid vaccine Vi polysaccharide - Bharat Biotech

Alternative Names: TYPBAR; Typbar-Vi; Typhoid polysaccharide vaccine - Bharat Biotech; Vi capsular polysaccharide typhoid vaccine I.P. - Bharat Biotech

Latest Information Update: 27 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bharat Biotech
  • Class Antibacterials; Bacterial vaccines; Polysaccharides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Typhoid

Most Recent Events

  • 17 Apr 2013 Launched for Typhoid (prevention) in Thailand (IM) before April 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top